Report Overview
The Global Non Invasive Aesthetic Treatments Market size is expected to be worth around US$ 140.8 Billion by 2034, from US$ 43.2 Billion in 2024, growing at a CAGR of 12.5% during the forecast period from 2025 to 2034. North America held a dominant market position, capturing more than a 41.4% share and holds US$ 17.8 Billion market value for the year.
Mass Non-Invasive Aesthetic Treatments Market, Global Analysis, 2020-2024 (US$ Billion)
| Region | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| North America | 9.9 | 12.6 | 14.7 | 16.2 | 17.9 |
| Europe | 5.8 | 7.4 | 8.8 | 9.9 | 11.0 |
| Asia Pacific | 4.0 | 5.4 | 6.7 | 7.8 | 9.2 |
Key Regions and Countries
- North America
- US
- Canada
- Europe
- Germany
- France
- The UK
- Spain
- Italy
- Russia
- Netherland
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- New Zealand
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
Key Players Analysis
The global non-invasive aesthetic treatment market is highly competitive, featuring prominent players such as AbbVie (AllerganAesthetics), Galderma S.A., Alma Lasers, Johnson & Johnson, Merz Aesthetics, and Venus Concept. These companies dominate the market through extensive product offerings, continuous innovation, and robust distribution networks. Further, companies such as Candela Corporation and Solta Medical also contribute significantly by focusing on various segments and advanced aesthetic devices.
The market is driven by the increasing aesthetics procedures, and advancements in technology. Strategic collaborations, product innovations, and expanding geographical reach are key strategies employed by these companies to maintain and enhance their market positions. Allergan, a global pharmaceutical company, is best known for its innovative products in the fields of medical aesthetics, eye care, neurosciences, and dermatology.
The company is a leader in non-invasive aesthetic treatments, offering popular products like Botox, Juvederm, and Kybella. Allergan focuses on enhancing patients’ well-being by developing breakthrough therapies and maintaining a strong presence in the aesthetic market. In addition, Galderma is a global dermatology company specializing in medical solutions for skin health.
The company offers a range of products in dermatology, including treatments for acne, rosacea, and wrinkles. Galderma is also a prominent player in the aesthetic market with products like Restylane (dermal fillers) and Dysport (botulinum toxin).
Top Key Players in the Non-Invasive Aesthetic Treatments Market
- Allergan Inc.
- Galderma S.A.
- Alma Lasers
- Syneron Candela
- Johnson & Johnson
- MerzPharma
- Lumenis Be Ltd.
- Solta Medical
- Cutera Inc.
- REVANCE AESTHETICS
Recent Developments
- In January 2024, Bausch Health Companies Inc. and Solta Medical, a global leader in the medical aesthetics market, announced the approval of Thermage® FLX and the TR-4 Return Pad by China’s National Medical Products Administration (NMPA). The TR-4 Return Pad is approved for use by the U.S. Food & Drug Administration (as part of the Thermage FLX device registration).
- In March 2024, Alma, a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, announced the launch of a special edition of Soprano Titanium to enable faster and more efficient hair removal sessions.